Search

Your search keyword '"KDM3A"' showing total 164 results

Search Constraints

Start Over You searched for: Descriptor "KDM3A" Remove constraint Descriptor: "KDM3A"
164 results on '"KDM3A"'

Search Results

1. KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer.

2. 干扰组蛋白去甲基化酶 KDM3A表达对肝星状 细胞增殖和胶原合成的影响.

3. LncRNA-PCat19 acts as a ceRNA of miR-378a-3p to facilitate microglia activation and accelerate chronic neuropathic pain in rats by promoting KDM3A-mediated BDNF demethylation.

4. KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer

5. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.

6. Lysine demethylase 3A promotes chondrogenic differentiation of aged human dental pulp stem cells.

8. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.

9. Lysine 68 Methylation‐Dependent SOX9 Stability Control Modulates Chondrogenic Differentiation in Dental Pulp Stem Cells.

10. KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis

11. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.

12. Lysine 68 Methylation‐Dependent SOX9 Stability Control Modulates Chondrogenic Differentiation in Dental Pulp Stem Cells

14. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development

15. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1.

16. The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer

17. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.

18. Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A.

19. Overexpression of hsa-miR-30a-5p and nonobstructive azoospermia: A case-control study.

20. Lysine demethylase 3A is a positive regulator of cardiac myofibroblast transdifferentiation that increases Smad3 phosphorylation following transforming growth factor beta1 stimulation.

21. Effects of KDM3A silencing on the apoptosis and invasion of human breast cancer cell line MDA-MB-231

22. KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65

23. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma

24. Dissecting the biological roles of Kdm3b and Kdm3a lysine demethylases

25. Reduction of H3K9 methylation by G9a inhibitors improves the development of mouse SCNT embryos.

26. MiR-216a-5p alleviates chronic constriction injury-induced neuropathic pain in rats by targeting KDM3A and inactivating Wnt/β-catenin signaling pathway.

27. Overexpression of let‐7d explains down‐regulated KDM3A and ENO2 in the pathogenesis of preeclampsia.

28. Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A/HOXA1/MEIS3 Pathway

29. Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A

30. Hsa-miR-27α-3p overexpression in men with nonobstructive azoospermia: A case-control study.

31. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma.

32. Lysine-specific demethylase 3A is important for autophagic occurrence.

33. LncRNA H19 ameliorates myocardial infarction‐induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A.

34. Lysine demethylase KDM3A alleviates hyperoxia-induced bronchopulmonary dysplasia in mice by promoting ETS1 expression.

35. The emerging role of histone demethylases in renal cell carcinoma

37. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.

38. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.

39. A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer.

40. KDM3A is not associated with metastasis and prognosis of breast cancer.

41. Overexpression of let‐7d explains down‐regulated KDM3A and ENO2 in the pathogenesis of preeclampsia

42. The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer

43. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis.

44. HIF-1α coordinates epigenetic activation of SIAH1 in hepatocytes in response to nutritional stress.

45. Protein arginine methylation: a prominent modification and its demethylation.

46. Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3.

47. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.

49. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L

50. Hsa-miR-27a-3p overexpression in men with nonobstructive azoospermia: A case-control study

Catalog

Books, media, physical & digital resources